Specialty supplement use and biologic measures of oxidative stress and DNA damage - PubMed (original) (raw)
Specialty supplement use and biologic measures of oxidative stress and DNA damage
Elizabeth D Kantor et al. Cancer Epidemiol Biomarkers Prev. 2013 Dec.
Abstract
Background: Oxidative stress and resulting cellular damage have been suggested to play a role in the etiology of several chronic diseases, including cancer and cardiovascular disease. Identifying factors associated with reduced oxidative stress and resulting damage may guide future disease-prevention strategies.
Methods: In the VITamins And Lifestyle (VITAL) biomarker study of 209 persons living in the Seattle area, we examined the association between current use of several specialty supplements and oxidative stress, DNA damage, and DNA repair capacity. Use of glucosamine, chondroitin, fish oil, methylsulfonylmethane (MSM), coenzyme Q10 (CoQ10), ginseng, ginkgo, and saw palmetto was ascertained by a supplement inventory/interview, whereas the use of fiber supplements was ascertained by questionnaire. Supplements used by more than 30 persons (glucosamine and chondroitin) were evaluated as the trend across number of pills/week (non-use, <14 pills/week, 14+ pills/week), whereas less commonly used supplements were evaluated as use/non-use. Oxidative stress was measured by urinary 8-isoprostane and PGF2α concentrations using enzyme immunoassays (EIA), whereas lymphocyte DNA damage and DNA repair capacity were measured using the Comet assay. Multivariate-adjusted linear regression was used to model the associations between supplement use and oxidative stress/DNA damage.
Results: Use of glucosamine (Ptrend: 0.01), chondroitin (Ptrend: 0.003), and fiber supplements (P: 0.01) was associated with reduced PGF2α concentrations, whereas CoQ10 supplementation was associated with reduced baseline DNA damage (P: 0.003).
Conclusions: Use of certain specialty supplements may be associated with reduced oxidative stress and DNA damage.
Impact: Further research is needed to evaluate the association between specialty supplement use and markers of oxidative stress and DNA damage.
©2013 AACR.
Conflict of interest statement
Conflict of interest: Study authors have no conflict of interest to declare
Similar articles
- Associations between glucosamine and chondroitin supplement use and biomarkers of systemic inflammation.
Kantor ED, Lampe JW, Navarro SL, Song X, Milne GL, White E. Kantor ED, et al. J Altern Complement Med. 2014 Jun;20(6):479-85. doi: 10.1089/acm.2013.0323. Epub 2014 Apr 16. J Altern Complement Med. 2014. PMID: 24738579 Free PMC article. - Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort.
Brasky TM, Kristal AR, Navarro SL, Lampe JW, Peters U, Patterson RE, White E. Brasky TM, et al. Nutr Cancer. 2011;63(4):573-82. doi: 10.1080/01635581.2011.553022. Nutr Cancer. 2011. PMID: 21598177 Free PMC article. - Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study.
Satia JA, Littman A, Slatore CG, Galanko JA, White E. Satia JA, et al. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1419-28. doi: 10.1158/1055-9965.EPI-09-0038. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19423520 Free PMC article. - Coenzyme Q10 Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases.
Gutierrez-Mariscal FM, Arenas-de Larriva AP, Limia-Perez L, Romero-Cabrera JL, Yubero-Serrano EM, López-Miranda J. Gutierrez-Mariscal FM, et al. Int J Mol Sci. 2020 Oct 23;21(21):7870. doi: 10.3390/ijms21217870. Int J Mol Sci. 2020. PMID: 33114148 Free PMC article. Review. - Glucosamine and chondroitin for osteoarthritis.
Huskisson EC. Huskisson EC. J Int Med Res. 2008 Nov-Dec;36(6):1161-79. doi: 10.1177/147323000803600602. J Int Med Res. 2008. PMID: 19094424 Review.
Cited by
- Glucosamine and Chondroitin Use in Relation to C-Reactive Protein Concentration: Results by Supplement Form, Formulation, and Dose.
Kantor ED, O'Connell K, Du M, Cao C, Zhang X, Lee DH, Cao Y, Giovannucci EL. Kantor ED, et al. J Altern Complement Med. 2021 Feb;27(2):150-159. doi: 10.1089/acm.2020.0283. Epub 2020 Dec 7. J Altern Complement Med. 2021. PMID: 33290138 Free PMC article. - Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans.
Navarro SL, White E, Kantor ED, Zhang Y, Rho J, Song X, Milne GL, Lampe PD, Lampe JW. Navarro SL, et al. PLoS One. 2015 Feb 26;10(2):e0117534. doi: 10.1371/journal.pone.0117534. eCollection 2015. PLoS One. 2015. PMID: 25719429 Free PMC article. Clinical Trial. - A Review of Natural Therapies Potentially Relevant in Triple Negative Breast Cancer Aimed at Targeting Cancer Cell Vulnerabilities.
Webb MJ, Kukard C. Webb MJ, et al. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420975861. doi: 10.1177/1534735420975861. Integr Cancer Ther. 2020. PMID: 33243021 Free PMC article. Review. - Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α.
van 't Erve TJ. van 't Erve TJ. Redox Biol. 2018 Jul;17:284-296. doi: 10.1016/j.redox.2018.05.003. Epub 2018 May 9. Redox Biol. 2018. PMID: 29775960 Free PMC article. - Expansion of the SOS regulon of Vibrio cholerae through extensive transcriptome analysis and experimental validation.
Krin E, Pierlé SA, Sismeiro O, Jagla B, Dillies MA, Varet H, Irazoki O, Campoy S, Rouy Z, Cruveiller S, Médigue C, Coppée JY, Mazel D. Krin E, et al. BMC Genomics. 2018 May 21;19(1):373. doi: 10.1186/s12864-018-4716-8. BMC Genomics. 2018. PMID: 29783948 Free PMC article.
References
- Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg. 2006;391(5):499–510. - PubMed
- Leufkens AM, van Duijnhoven FJ, Woudt SH, Siersema PD, Jenab M, Jansen EH, et al. Biomarkers of oxidative stress and risk of developing colorectal cancer: a cohort-nested case-control study in the European Prospective Investigation Into Cancer and Nutrition. Am J Epidemiol. 2012;175:653–63. - PubMed
- Zhang ZJ. Systematic review on the association between F2-isoprostanes and cardiovascular disease. Ann Clin Biochem. 2013;50:108–14. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K05 CA124911/CA/NCI NIH HHS/United States
- K05 CA154337/CA/NCI NIH HHS/United States
- R01CA142545/CA/NCI NIH HHS/United States
- R25 CA094880/CA/NCI NIH HHS/United States
- R01 CA142545/CA/NCI NIH HHS/United States
- R25CA094880/CA/NCI NIH HHS/United States
- R03 CA105336/CA/NCI NIH HHS/United States
- R03CA105336/CA/NCI NIH HHS/United States
- K05CA154337/CA/NCI NIH HHS/United States
- K05CA124911/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical